What was the price per share for the DHC equity award granted to Jeffrey P. Somers?

The 12,401 Common Shares of Beneficial Interest granted to Jeffrey P. Somers were reported at a transaction price of $0.00 per share. This indicates a compensatory equity grant under Diversified Healthcare Trust’s equity compensation plan rather than an open-market purchase transaction.

DHC director receives 12,401-share equity grant

SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.

Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.

Insider Trade Summary

Grant/Award: 12,401 shares

Grant/Award 1 txn

Insider SOMERS JEFFREY P.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares of Beneficial Interest	12,401	$0.00	$0.00

Holdings After Transaction: Common Shares of Beneficial Interest — 177,079 shares (Direct)

Footnotes (1)

F1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.

Key Figures

Equity award shares: 12,401 shares Award price per share: $0.00 per share Shares held after grant: 177,079 shares

3 metrics

Equity award shares 12,401 shares Common Shares of Beneficial Interest granted June 10, 2026

Award price per share $0.00 per share Reported transaction price for equity grant

Shares held after grant 177,079 shares Total direct holdings following transaction

Key Terms

Common Shares of Beneficial Interest, equity compensation plan, Grant, award, or other acquisition

3 terms

Common Shares of Beneficial Interest financial

"security_title: "Common Shares of Beneficial Interest""

Common Shares of Beneficial Interest are units that represent ownership in a company or organization, like owning a piece of a pie. They give investors voting rights and a chance to share in profits, making them important for those looking to invest and have a say in how the organization is run.

equity compensation plan financial

"award of shares pursuant to the Issuer's equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DHC director Jeffrey P. Somers report on this Form 4?

Jeffrey P. Somers reported receiving an award of 12,401 Common Shares of Beneficial Interest. The shares were granted on June 10, 2026, as part of Diversified Healthcare Trust’s equity compensation plan and were recorded at a stated price of $0.00 per share.

How many DHC shares does Jeffrey P. Somers hold after this equity award?

After the June 10, 2026 award, Jeffrey P. Somers directly holds 177,079 Common Shares of Beneficial Interest in Diversified Healthcare Trust. This total includes the 12,401 shares granted under the issuer’s equity compensation plan as reported in the Form 4 filing.

Was the DHC insider transaction for Jeffrey P. Somers a purchase or an equity grant?

The transaction was an equity grant, not a market purchase. The Form 4 classifies it under code A, described as a grant, award, or other acquisition, with 12,401 shares awarded pursuant to Diversified Healthcare Trust’s equity compensation plan at a stated price of $0.00 per share.

Does the Form 4 for DHC indicate any derivative securities or option exercises for Jeffrey P. Somers?

The filing does not report any derivative securities or option exercises for Jeffrey P. Somers. It shows a single non-derivative transaction: an award of 12,401 Common Shares of Beneficial Interest under Diversified Healthcare Trust’s equity compensation plan, with no derivative positions listed afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/12/2026 - 04:23 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOMERS JEFFREY P.

(Last)

(First)

(Middle)

C/O THE RMR GROUP LLC

TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)

NEWTON

MASSACHUSETTS

02458

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares of Beneficial Interest	06/10/2026		A		12,401	A	⁽¹⁾	177,079	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.

	/s/ Jeffrey P. Somers	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR